 Robert Wilson
Concepts (512)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 113 | 2022 | 1075 | 12.350 |
Why?
| | Aging | 100 | 2022 | 1614 | 10.540 |
Why?
| | Alzheimer Disease | 114 | 2022 | 1829 | 9.400 |
Why?
| | Cognition | 83 | 2022 | 1206 | 7.370 |
Why?
| | Dementia | 37 | 2022 | 545 | 6.470 |
Why?
| | Longitudinal Studies | 122 | 2021 | 1452 | 5.920 |
Why?
| | Aged, 80 and over | 212 | 2022 | 5234 | 5.880 |
Why?
| | Aged | 253 | 2022 | 10295 | 5.330 |
Why?
| | Neuropsychological Tests | 98 | 2020 | 1300 | 4.490 |
Why?
| | Brain | 55 | 2021 | 1655 | 4.460 |
Why?
| | Male | 263 | 2022 | 17583 | 4.140 |
Why?
| | Female | 262 | 2022 | 18253 | 4.060 |
Why?
| | African Americans | 42 | 2021 | 818 | 3.710 |
Why?
| | Olfaction Disorders | 8 | 2021 | 54 | 3.470 |
Why?
| | Humans | 289 | 2022 | 31481 | 3.390 |
Why?
| | Memory | 23 | 2018 | 343 | 3.080 |
Why?
| | Lewy Bodies | 10 | 2021 | 193 | 2.940 |
Why?
| | Depression | 21 | 2016 | 516 | 2.740 |
Why?
| | Memory, Episodic | 9 | 2020 | 105 | 2.670 |
Why?
| | Cohort Studies | 63 | 2022 | 2014 | 2.370 |
Why?
| | Disease Progression | 35 | 2020 | 861 | 2.370 |
Why?
| | Educational Status | 23 | 2021 | 291 | 2.320 |
Why?
| | Personality | 7 | 2015 | 68 | 2.220 |
Why?
| | Memory Disorders | 11 | 2019 | 181 | 2.200 |
Why?
| | Stress, Psychological | 11 | 2021 | 281 | 2.160 |
Why?
| | DNA-Binding Proteins | 9 | 2019 | 264 | 2.100 |
Why?
| | Risk Factors | 63 | 2022 | 2664 | 1.680 |
Why?
| | Independent Living | 14 | 2022 | 257 | 1.650 |
Why?
| | Neurodegenerative Diseases | 5 | 2021 | 119 | 1.640 |
Why?
| | Apolipoproteins E | 18 | 2018 | 205 | 1.620 |
Why?
| | Follow-Up Studies | 42 | 2020 | 2028 | 1.580 |
Why?
| | Chicago | 41 | 2022 | 955 | 1.530 |
Why?
| | Mortality | 11 | 2021 | 99 | 1.480 |
Why?
| | Health Literacy | 7 | 2021 | 102 | 1.460 |
Why?
| | Interpersonal Relations | 8 | 2014 | 114 | 1.450 |
Why?
| | Autopsy | 18 | 2021 | 340 | 1.440 |
Why?
| | Apolipoprotein E4 | 19 | 2019 | 218 | 1.430 |
Why?
| | Cerebral Infarction | 8 | 2015 | 159 | 1.390 |
Why?
| | Motor Activity | 18 | 2015 | 397 | 1.370 |
Why?
| | Hospitalization | 5 | 2019 | 359 | 1.350 |
Why?
| | Lewy Body Disease | 6 | 2021 | 106 | 1.290 |
Why?
| | Geriatric Assessment | 24 | 2017 | 232 | 1.290 |
Why?
| | Incidence | 30 | 2020 | 829 | 1.260 |
Why?
| | Loneliness | 7 | 2020 | 51 | 1.200 |
Why?
| | Activities of Daily Living | 23 | 2013 | 495 | 1.190 |
Why?
| | Neurofibrillary Tangles | 10 | 2017 | 174 | 1.180 |
Why?
| | Learning | 2 | 2018 | 89 | 1.160 |
Why?
| | Anxiety | 4 | 2013 | 162 | 1.140 |
Why?
| | Memory, Short-Term | 6 | 2019 | 99 | 1.120 |
Why?
| | Decision Making | 10 | 2021 | 232 | 1.100 |
Why?
| | Parkinsonian Disorders | 9 | 2019 | 210 | 1.090 |
Why?
| | Neurotic Disorders | 6 | 2018 | 19 | 1.070 |
Why?
| | Age Factors | 26 | 2021 | 943 | 1.060 |
Why?
| | Middle Aged | 49 | 2021 | 11209 | 1.060 |
Why?
| | Proportional Hazards Models | 23 | 2019 | 390 | 1.030 |
Why?
| | Hippocampus | 7 | 2020 | 295 | 1.030 |
Why?
| | Death | 5 | 2021 | 45 | 1.010 |
Why?
| | Substantia Nigra | 4 | 2021 | 157 | 1.010 |
Why?
| | Age of Onset | 4 | 2021 | 113 | 0.990 |
Why?
| | Perception | 4 | 2021 | 92 | 0.990 |
Why?
| | Risk | 19 | 2019 | 228 | 0.960 |
Why?
| | Agnosia | 2 | 2016 | 10 | 0.950 |
Why?
| | Neurons | 4 | 2013 | 407 | 0.950 |
Why?
| | Cerebral Cortex | 3 | 2021 | 206 | 0.920 |
Why?
| | United States | 31 | 2021 | 2539 | 0.900 |
Why?
| | Life Style | 5 | 2021 | 219 | 0.900 |
Why?
| | Disabled Persons | 7 | 2019 | 119 | 0.900 |
Why?
| | Exercise | 8 | 2022 | 454 | 0.850 |
Why?
| | Genetic Predisposition to Disease | 12 | 2017 | 462 | 0.850 |
Why?
| | Amygdala | 1 | 2021 | 56 | 0.840 |
Why?
| | Research Design | 5 | 2020 | 238 | 0.820 |
Why?
| | Language | 3 | 2014 | 79 | 0.810 |
Why?
| | Prospective Studies | 32 | 2022 | 1934 | 0.810 |
Why?
| | Choice Behavior | 2 | 2019 | 61 | 0.810 |
Why?
| | Psychomotor Performance | 9 | 2021 | 258 | 0.800 |
Why?
| | Amyloid beta-Peptides | 5 | 2017 | 248 | 0.800 |
Why?
| | Neocortex | 2 | 2019 | 36 | 0.790 |
Why?
| | Olfactory Bulb | 1 | 2019 | 13 | 0.770 |
Why?
| | Child Abuse | 2 | 2012 | 36 | 0.760 |
Why?
| | Anxiety Disorders | 3 | 2016 | 176 | 0.740 |
Why?
| | Music | 2 | 2021 | 24 | 0.730 |
Why?
| | Reward | 1 | 2019 | 34 | 0.730 |
Why?
| | Prodromal Symptoms | 1 | 2019 | 20 | 0.730 |
Why?
| | Nervous System Diseases | 4 | 2019 | 145 | 0.720 |
Why?
| | Cognitive Reserve | 1 | 2019 | 32 | 0.720 |
Why?
| | Chronic Disease | 5 | 2017 | 544 | 0.710 |
Why?
| | Reading | 5 | 2021 | 41 | 0.710 |
Why?
| | Genotype | 18 | 2018 | 423 | 0.690 |
Why?
| | Psychiatric Status Rating Scales | 12 | 2016 | 386 | 0.680 |
Why?
| | Severity of Illness Index | 16 | 2021 | 1240 | 0.680 |
Why?
| | Comorbidity | 15 | 2020 | 562 | 0.650 |
Why?
| | Awareness | 4 | 2019 | 49 | 0.650 |
Why?
| | Brain Stem | 2 | 2016 | 26 | 0.640 |
Why?
| | Ambulatory Care | 1 | 2017 | 90 | 0.620 |
Why?
| | Depressive Disorder | 4 | 2019 | 212 | 0.620 |
Why?
| | Locus Coeruleus | 2 | 2013 | 24 | 0.620 |
Why?
| | Brain Diseases | 3 | 2020 | 90 | 0.600 |
Why?
| | Urban Population | 4 | 2013 | 161 | 0.600 |
Why?
| | Mobility Limitation | 7 | 2019 | 100 | 0.590 |
Why?
| | Brain Chemistry | 1 | 2016 | 53 | 0.590 |
Why?
| | Longevity | 2 | 2013 | 35 | 0.570 |
Why?
| | Motor Skills | 2 | 2013 | 64 | 0.570 |
Why?
| | Plaque, Amyloid | 7 | 2017 | 146 | 0.560 |
Why?
| | Depressive Disorder, Major | 1 | 2016 | 110 | 0.550 |
Why?
| | Alleles | 12 | 2018 | 221 | 0.530 |
Why?
| | Multilingualism | 1 | 2014 | 20 | 0.530 |
Why?
| | Frail Elderly | 5 | 2014 | 50 | 0.520 |
Why?
| | Cross-Sectional Studies | 16 | 2021 | 986 | 0.520 |
Why?
| | Blood Pressure | 5 | 2020 | 260 | 0.520 |
Why?
| | Quality of Life | 3 | 2015 | 663 | 0.510 |
Why?
| | Mesencephalon | 1 | 2013 | 48 | 0.510 |
Why?
| | Sex Factors | 13 | 2020 | 542 | 0.500 |
Why?
| | Mental Recall | 6 | 2020 | 74 | 0.500 |
Why?
| | Disability Evaluation | 12 | 2015 | 332 | 0.490 |
Why?
| | Population Surveillance | 5 | 2021 | 127 | 0.480 |
Why?
| | Time Factors | 16 | 2021 | 1902 | 0.480 |
Why?
| | Personal Satisfaction | 1 | 2013 | 52 | 0.470 |
Why?
| | Membrane Transport Proteins | 3 | 2017 | 51 | 0.470 |
Why?
| | TDP-43 Proteinopathies | 3 | 2020 | 102 | 0.460 |
Why?
| | Emotions | 1 | 2012 | 98 | 0.440 |
Why?
| | Mental Health | 2 | 2016 | 119 | 0.440 |
Why?
| | Movement Disorders | 4 | 2021 | 150 | 0.430 |
Why?
| | Family | 3 | 2021 | 111 | 0.430 |
Why?
| | Muscle Strength | 6 | 2009 | 134 | 0.420 |
Why?
| | Sclerosis | 4 | 2020 | 69 | 0.420 |
Why?
| | Residence Characteristics | 9 | 2015 | 226 | 0.420 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2018 | 224 | 0.410 |
Why?
| | Knowledge | 1 | 2010 | 20 | 0.410 |
Why?
| | Family Health | 1 | 2010 | 38 | 0.410 |
Why?
| | Telephone | 1 | 2010 | 33 | 0.410 |
Why?
| | Reaction Time | 3 | 2020 | 128 | 0.400 |
Why?
| | tau Proteins | 5 | 2020 | 174 | 0.400 |
Why?
| | Diet | 4 | 2010 | 202 | 0.400 |
Why?
| | Psychological Tests | 4 | 2013 | 63 | 0.390 |
Why?
| | Tissue Donors | 2 | 2020 | 79 | 0.380 |
Why?
| | Linear Models | 12 | 2017 | 276 | 0.380 |
Why?
| | Prefrontal Cortex | 3 | 2021 | 152 | 0.380 |
Why?
| | Delivery of Health Care | 3 | 2020 | 130 | 0.380 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 467 | 0.370 |
Why?
| | Mental Status Schedule | 9 | 2017 | 121 | 0.370 |
Why?
| | Psychometrics | 11 | 2012 | 287 | 0.370 |
Why?
| | Life | 2 | 2006 | 7 | 0.370 |
Why?
| | Interviews as Topic | 3 | 2021 | 152 | 0.370 |
Why?
| | Clergy | 11 | 2013 | 87 | 0.360 |
Why?
| | Cerebral Amyloid Angiopathy | 3 | 2015 | 101 | 0.360 |
Why?
| | Risk Assessment | 11 | 2022 | 806 | 0.350 |
Why?
| | Models, Psychological | 5 | 2015 | 89 | 0.350 |
Why?
| | Antioxidants | 3 | 2005 | 70 | 0.350 |
Why?
| | Social Class | 2 | 2005 | 71 | 0.340 |
Why?
| | Language Tests | 2 | 2013 | 38 | 0.340 |
Why?
| | Social Support | 4 | 2014 | 224 | 0.330 |
Why?
| | Homes for the Aged | 1 | 2007 | 9 | 0.330 |
Why?
| | Logistic Models | 8 | 2017 | 479 | 0.330 |
Why?
| | Neurologic Examination | 3 | 2020 | 160 | 0.330 |
Why?
| | Nursing Homes | 1 | 2007 | 42 | 0.320 |
Why?
| | Financial Management | 2 | 2020 | 25 | 0.320 |
Why?
| | Stroke | 3 | 2016 | 367 | 0.320 |
Why?
| | Parkinson Disease | 7 | 2017 | 1180 | 0.320 |
Why?
| | Feeding Behavior | 2 | 2005 | 122 | 0.320 |
Why?
| | Dietary Fats | 2 | 2006 | 40 | 0.320 |
Why?
| | Community Health Planning | 3 | 2011 | 21 | 0.320 |
Why?
| | Vitamin E | 3 | 2005 | 44 | 0.320 |
Why?
| | Intelligence | 1 | 2006 | 28 | 0.310 |
Why?
| | Decision Support Techniques | 1 | 2006 | 55 | 0.310 |
Why?
| | Smell | 2 | 2016 | 20 | 0.310 |
Why?
| | Personality Disorders | 1 | 2006 | 21 | 0.300 |
Why?
| | Risk-Taking | 1 | 2006 | 40 | 0.300 |
Why?
| | Income | 4 | 2020 | 77 | 0.300 |
Why?
| | Adult | 15 | 2020 | 9779 | 0.300 |
Why?
| | Fish Products | 1 | 2005 | 2 | 0.300 |
Why?
| | Delusions | 1 | 2005 | 13 | 0.300 |
Why?
| | Social Behavior | 5 | 2011 | 108 | 0.300 |
Why?
| | Fishes | 1 | 2005 | 5 | 0.300 |
Why?
| | Health Status | 8 | 2019 | 249 | 0.290 |
Why?
| | Membrane Proteins | 2 | 2021 | 230 | 0.290 |
Why?
| | Models, Statistical | 6 | 2021 | 144 | 0.280 |
Why?
| | Factor Analysis, Statistical | 3 | 2015 | 76 | 0.280 |
Why?
| | Child | 5 | 2020 | 1572 | 0.280 |
Why?
| | Diet Surveys | 2 | 2006 | 26 | 0.280 |
Why?
| | Genetic Variation | 3 | 2017 | 113 | 0.280 |
Why?
| | Hallucinations | 1 | 2005 | 94 | 0.280 |
Why?
| | Mood Disorders | 1 | 2005 | 34 | 0.280 |
Why?
| | Reproducibility of Results | 7 | 2012 | 886 | 0.270 |
Why?
| | Space Perception | 2 | 2019 | 45 | 0.270 |
Why?
| | Nutrition Disorders | 1 | 2003 | 9 | 0.260 |
Why?
| | Self Report | 3 | 2015 | 225 | 0.260 |
Why?
| | Predictive Value of Tests | 7 | 2021 | 637 | 0.260 |
Why?
| | Personality Inventory | 4 | 2009 | 87 | 0.260 |
Why?
| | Life Change Events | 2 | 2014 | 42 | 0.260 |
Why?
| | Anger | 1 | 2003 | 31 | 0.250 |
Why?
| | Affect | 1 | 2003 | 72 | 0.250 |
Why?
| | Gait Disorders, Neurologic | 5 | 2009 | 150 | 0.240 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2016 | 332 | 0.240 |
Why?
| | Social Adjustment | 3 | 2009 | 32 | 0.240 |
Why?
| | Diabetes Complications | 3 | 2016 | 74 | 0.240 |
Why?
| | Fraud | 2 | 2021 | 15 | 0.240 |
Why?
| | Catholicism | 5 | 2013 | 21 | 0.240 |
Why?
| | Cause of Death | 2 | 2021 | 78 | 0.240 |
Why?
| | Prevalence | 5 | 2021 | 544 | 0.240 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2006 | 226 | 0.240 |
Why?
| | Prognosis | 5 | 2020 | 1028 | 0.240 |
Why?
| | Vitamin A | 1 | 2002 | 8 | 0.240 |
Why?
| | Carotenoids | 1 | 2002 | 15 | 0.240 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2020 | 36 | 0.240 |
Why?
| | Magnetic Resonance Imaging | 7 | 2020 | 1273 | 0.230 |
Why?
| | Leg | 3 | 2007 | 51 | 0.230 |
Why?
| | Radar | 1 | 2022 | 6 | 0.230 |
Why?
| | Self Stimulation | 1 | 2002 | 12 | 0.230 |
Why?
| | Intermediate Filaments | 1 | 2022 | 11 | 0.230 |
Why?
| | Cerebrovascular Disorders | 3 | 2020 | 123 | 0.230 |
Why?
| | Antihypertensive Agents | 3 | 2020 | 91 | 0.230 |
Why?
| | Reference Values | 3 | 2020 | 260 | 0.220 |
Why?
| | Cerebral Arterial Diseases | 1 | 2021 | 9 | 0.220 |
Why?
| | Elder Abuse | 1 | 2022 | 35 | 0.220 |
Why?
| | Statistics, Nonparametric | 4 | 2015 | 156 | 0.220 |
Why?
| | Health Behavior | 3 | 2020 | 177 | 0.210 |
Why?
| | Brazil | 4 | 2021 | 37 | 0.210 |
Why?
| | Social Discrimination | 1 | 2021 | 6 | 0.210 |
Why?
| | Epidemiologic Studies | 3 | 2012 | 24 | 0.210 |
Why?
| | Serial Learning | 1 | 2020 | 8 | 0.210 |
Why?
| | Neurofilament Proteins | 1 | 2020 | 6 | 0.210 |
Why?
| | Musculoskeletal Diseases | 2 | 2010 | 32 | 0.200 |
Why?
| | Peptides | 1 | 2021 | 116 | 0.200 |
Why?
| | Socioeconomic Factors | 5 | 2018 | 362 | 0.200 |
Why?
| | Muscle Rigidity | 3 | 2014 | 27 | 0.200 |
Why?
| | Synapses | 2 | 2012 | 52 | 0.200 |
Why?
| | Child Development | 1 | 2020 | 78 | 0.190 |
Why?
| | Confidence Intervals | 7 | 2017 | 102 | 0.190 |
Why?
| | Smoking | 3 | 2012 | 202 | 0.190 |
Why?
| | Social Environment | 2 | 2012 | 93 | 0.180 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 9 | 0.180 |
Why?
| | Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 27 | 0.180 |
Why?
| | Emergencies | 1 | 2019 | 41 | 0.180 |
Why?
| | Haplotypes | 2 | 2017 | 63 | 0.180 |
Why?
| | Cardiovascular Diseases | 2 | 2017 | 410 | 0.180 |
Why?
| | Visual Perception | 2 | 2011 | 69 | 0.180 |
Why?
| | Primary Prevention | 1 | 2019 | 53 | 0.180 |
Why?
| | Economics | 1 | 2018 | 23 | 0.170 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 59 | 0.170 |
Why?
| | Parents | 2 | 2012 | 111 | 0.170 |
Why?
| | Odds Ratio | 6 | 2017 | 327 | 0.170 |
Why?
| | Illinois | 5 | 2020 | 266 | 0.170 |
Why?
| | Genome-Wide Association Study | 3 | 2016 | 315 | 0.170 |
Why?
| | Patient Acceptance of Health Care | 1 | 2019 | 85 | 0.170 |
Why?
| | Osteoporosis | 1 | 2018 | 74 | 0.170 |
Why?
| | Blood Glucose | 1 | 2018 | 137 | 0.170 |
Why?
| | Gait | 5 | 2014 | 395 | 0.170 |
Why?
| | Urinary Incontinence | 1 | 2017 | 25 | 0.170 |
Why?
| | Pain | 2 | 2010 | 336 | 0.160 |
Why?
| | Apolipoprotein E3 | 1 | 2017 | 15 | 0.160 |
Why?
| | Homozygote | 1 | 2017 | 28 | 0.160 |
Why?
| | Education | 3 | 2006 | 42 | 0.160 |
Why?
| | Brain Infarction | 3 | 2016 | 78 | 0.160 |
Why?
| | Neoplasms | 2 | 2018 | 280 | 0.160 |
Why?
| | Polymorphism, Genetic | 1 | 2017 | 87 | 0.160 |
Why?
| | Gene Expression | 1 | 2018 | 272 | 0.160 |
Why?
| | Biostatistics | 1 | 2016 | 6 | 0.150 |
Why?
| | Child, Preschool | 2 | 2022 | 786 | 0.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 230 | 0.150 |
Why?
| | Prejudice | 2 | 2008 | 43 | 0.150 |
Why?
| | Employment | 1 | 2016 | 39 | 0.150 |
Why?
| | Statistics as Topic | 4 | 2017 | 124 | 0.150 |
Why?
| | Age Distribution | 3 | 2011 | 110 | 0.140 |
Why?
| | Attention | 3 | 2005 | 163 | 0.140 |
Why?
| | Empathy | 1 | 2014 | 43 | 0.140 |
Why?
| | Dancing | 1 | 2014 | 10 | 0.130 |
Why?
| | Harm Reduction | 1 | 2014 | 6 | 0.130 |
Why?
| | Raphe Nuclei | 1 | 2013 | 8 | 0.130 |
Why?
| | Ventral Tegmental Area | 1 | 2013 | 12 | 0.130 |
Why?
| | Locomotion | 1 | 2014 | 39 | 0.130 |
Why?
| | Regression Analysis | 5 | 2018 | 319 | 0.130 |
Why?
| | Cell Count | 1 | 2013 | 115 | 0.130 |
Why?
| | Cholinergic Antagonists | 1 | 2013 | 16 | 0.130 |
Why?
| | Religion | 1 | 2013 | 40 | 0.120 |
Why?
| | Social Isolation | 2 | 2018 | 26 | 0.120 |
Why?
| | Survival Analysis | 2 | 2005 | 379 | 0.120 |
Why?
| | Nerve Degeneration | 1 | 2013 | 57 | 0.120 |
Why?
| | Hypokinesia | 2 | 2014 | 26 | 0.120 |
Why?
| | Medicare | 3 | 2019 | 113 | 0.120 |
Why?
| | Health Status Disparities | 1 | 2013 | 70 | 0.120 |
Why?
| | Religion and Psychology | 2 | 2010 | 26 | 0.120 |
Why?
| | Anomie | 1 | 2012 | 4 | 0.120 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2012 | 16 | 0.110 |
Why?
| | Patient Dropouts | 1 | 2012 | 31 | 0.110 |
Why?
| | Hydrocortisone | 1 | 2012 | 54 | 0.110 |
Why?
| | Health Promotion | 1 | 2014 | 186 | 0.110 |
Why?
| | Personality Assessment | 3 | 2006 | 41 | 0.110 |
Why?
| | Association | 1 | 2011 | 8 | 0.110 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2012 | 60 | 0.110 |
Why?
| | Insulin Resistance | 1 | 2012 | 71 | 0.110 |
Why?
| | Young Adult | 3 | 2013 | 2277 | 0.110 |
Why?
| | Post-Synaptic Density | 1 | 2011 | 2 | 0.110 |
Why?
| | Corticosterone | 1 | 2011 | 4 | 0.110 |
Why?
| | Receptors, Complement 3b | 1 | 2011 | 15 | 0.110 |
Why?
| | Tremor | 2 | 2014 | 136 | 0.110 |
Why?
| | Microfilament Proteins | 1 | 2011 | 33 | 0.110 |
Why?
| | Endophenotypes | 1 | 2011 | 13 | 0.110 |
Why?
| | Retrospective Studies | 3 | 2021 | 3591 | 0.110 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 35 | 0.110 |
Why?
| | Wechsler Scales | 2 | 2010 | 15 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2012 | 187 | 0.100 |
Why?
| | Motor Skills Disorders | 1 | 2010 | 20 | 0.100 |
Why?
| | Genetic Association Studies | 3 | 2017 | 90 | 0.100 |
Why?
| | CA3 Region, Hippocampal | 1 | 2010 | 7 | 0.100 |
Why?
| | Microtubule-Associated Proteins | 1 | 2010 | 24 | 0.100 |
Why?
| | Cost-Benefit Analysis | 1 | 2011 | 153 | 0.100 |
Why?
| | Diet, Mediterranean | 1 | 2010 | 57 | 0.100 |
Why?
| | Self Care | 1 | 2010 | 104 | 0.100 |
Why?
| | Immunohistochemistry | 4 | 2017 | 494 | 0.100 |
Why?
| | Life Expectancy | 1 | 2009 | 22 | 0.090 |
Why?
| | Somatosensory Disorders | 1 | 2009 | 10 | 0.090 |
Why?
| | HIV Infections | 1 | 2017 | 951 | 0.090 |
Why?
| | Hostility | 1 | 2009 | 21 | 0.090 |
Why?
| | Sensory Thresholds | 1 | 2009 | 26 | 0.090 |
Why?
| | Adolescent | 2 | 2013 | 2667 | 0.090 |
Why?
| | Vibration | 1 | 2009 | 29 | 0.090 |
Why?
| | Financing, Personal | 2 | 2019 | 24 | 0.090 |
Why?
| | Caspase 3 | 1 | 2008 | 29 | 0.090 |
Why?
| | Amyloid | 2 | 2010 | 52 | 0.090 |
Why?
| | Differential Threshold | 1 | 2008 | 3 | 0.090 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2005 | 21 | 0.090 |
Why?
| | Hemoglobins | 1 | 2008 | 81 | 0.090 |
Why?
| | Data Collection | 2 | 2005 | 120 | 0.080 |
Why?
| | Survival Rate | 1 | 2009 | 465 | 0.080 |
Why?
| | Executive Function | 2 | 2021 | 109 | 0.080 |
Why?
| | Hand Strength | 1 | 2007 | 61 | 0.080 |
Why?
| | Personal Space | 1 | 2007 | 7 | 0.080 |
Why?
| | Perceptual Disorders | 1 | 2006 | 7 | 0.080 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 111 | 0.080 |
Why?
| | Latin America | 1 | 2006 | 7 | 0.080 |
Why?
| | Likelihood Functions | 2 | 2017 | 31 | 0.080 |
Why?
| | Copper | 1 | 2006 | 7 | 0.080 |
Why?
| | Trans Fatty Acids | 1 | 2006 | 4 | 0.080 |
Why?
| | Spouses | 1 | 2006 | 29 | 0.080 |
Why?
| | Dyskinesias | 1 | 2006 | 36 | 0.080 |
Why?
| | Fatty Acids | 1 | 2006 | 45 | 0.080 |
Why?
| | Ambulatory Care Facilities | 1 | 2006 | 42 | 0.080 |
Why?
| | Disease Susceptibility | 1 | 2006 | 80 | 0.080 |
Why?
| | Fear | 1 | 2006 | 51 | 0.080 |
Why?
| | Psychology | 1 | 2006 | 24 | 0.080 |
Why?
| | Data Interpretation, Statistical | 3 | 2016 | 96 | 0.070 |
Why?
| | Parent-Child Relations | 1 | 2006 | 37 | 0.070 |
Why?
| | Urban Health | 1 | 2006 | 29 | 0.070 |
Why?
| | Population Groups | 1 | 2005 | 5 | 0.070 |
Why?
| | Verbal Learning | 2 | 2004 | 43 | 0.070 |
Why?
| | Patient Readmission | 1 | 2007 | 129 | 0.070 |
Why?
| | Parkinson Disease, Secondary | 1 | 2005 | 29 | 0.070 |
Why?
| | Dentin | 1 | 2005 | 1 | 0.070 |
Why?
| | Molar, Third | 1 | 2005 | 1 | 0.070 |
Why?
| | Dentin-Bonding Agents | 1 | 2005 | 1 | 0.070 |
Why?
| | Dental Etching | 1 | 2005 | 1 | 0.070 |
Why?
| | DNA | 1 | 2005 | 139 | 0.070 |
Why?
| | Tocopherols | 1 | 2005 | 5 | 0.070 |
Why?
| | Family Characteristics | 1 | 2005 | 22 | 0.070 |
Why?
| | Eating | 1 | 2005 | 61 | 0.070 |
Why?
| | Water | 1 | 2005 | 37 | 0.070 |
Why?
| | Energy Intake | 1 | 2005 | 99 | 0.070 |
Why?
| | Parenting | 1 | 2006 | 78 | 0.070 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2005 | 43 | 0.070 |
Why?
| | Sex Distribution | 3 | 2011 | 89 | 0.070 |
Why?
| | Sensitivity and Specificity | 3 | 2010 | 580 | 0.070 |
Why?
| | Postural Balance | 3 | 2014 | 127 | 0.060 |
Why?
| | Markov Chains | 2 | 2015 | 32 | 0.060 |
Why?
| | Heterozygote | 2 | 2015 | 115 | 0.060 |
Why?
| | Seafood | 1 | 2003 | 12 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2006 | 389 | 0.060 |
Why?
| | Brief Psychiatric Rating Scale | 2 | 2015 | 8 | 0.060 |
Why?
| | Brain Mapping | 3 | 2012 | 199 | 0.060 |
Why?
| | Sleep | 1 | 2006 | 357 | 0.060 |
Why?
| | Health Surveys | 2 | 2013 | 102 | 0.060 |
Why?
| | Frontal Lobe | 1 | 2002 | 87 | 0.060 |
Why?
| | Mathematics | 1 | 2021 | 36 | 0.050 |
Why?
| | Atrophy | 1 | 2021 | 108 | 0.050 |
Why?
| | Hypertension | 2 | 2020 | 283 | 0.050 |
Why?
| | Writing | 1 | 2021 | 22 | 0.050 |
Why?
| | Attitude to Death | 1 | 2020 | 14 | 0.050 |
Why?
| | Cost of Illness | 1 | 2021 | 65 | 0.050 |
Why?
| | Interview, Psychological | 2 | 2014 | 45 | 0.050 |
Why?
| | Southeastern United States | 1 | 2020 | 15 | 0.050 |
Why?
| | Tissue and Organ Procurement | 1 | 2020 | 37 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2020 | 76 | 0.050 |
Why?
| | Midwestern United States | 1 | 2020 | 73 | 0.050 |
Why?
| | Animals | 2 | 2011 | 5312 | 0.050 |
Why?
| | Intelligence Tests | 2 | 2014 | 17 | 0.050 |
Why?
| | Focus Groups | 1 | 2020 | 93 | 0.050 |
Why?
| | Neuroimaging | 1 | 2020 | 126 | 0.050 |
Why?
| | Blotting, Western | 2 | 2011 | 225 | 0.050 |
Why?
| | Minority Groups | 1 | 2020 | 79 | 0.050 |
Why?
| | Body Mass Index | 2 | 2016 | 458 | 0.050 |
Why?
| | Nutrition Assessment | 3 | 2005 | 53 | 0.050 |
Why?
| | HSP27 Heat-Shock Proteins | 1 | 2019 | 19 | 0.050 |
Why?
| | Muscle Strength Dynamometer | 2 | 2009 | 16 | 0.040 |
Why?
| | Proteomics | 1 | 2019 | 80 | 0.040 |
Why?
| | Religious Personnel | 1 | 2018 | 11 | 0.040 |
Why?
| | Epidemiologic Research Design | 2 | 2010 | 16 | 0.040 |
Why?
| | Dementia, Vascular | 1 | 2018 | 42 | 0.040 |
Why?
| | Genetic Linkage | 1 | 2017 | 43 | 0.040 |
Why?
| | Diagnosis | 1 | 2017 | 24 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2018 | 158 | 0.040 |
Why?
| | Genotyping Techniques | 1 | 2017 | 11 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2018 | 559 | 0.040 |
Why?
| | Tuberous Sclerosis | 1 | 2017 | 14 | 0.040 |
Why?
| | Arteriolosclerosis | 1 | 2016 | 48 | 0.040 |
Why?
| | Anisotropy | 1 | 2016 | 58 | 0.040 |
Why?
| | White Matter | 1 | 2018 | 145 | 0.040 |
Why?
| | Hypoglycemic Agents | 1 | 2016 | 76 | 0.040 |
Why?
| | Diffusion Tensor Imaging | 1 | 2016 | 78 | 0.040 |
Why?
| | Demography | 1 | 2016 | 83 | 0.040 |
Why?
| | Inflammation | 1 | 2018 | 360 | 0.040 |
Why?
| | Pattern Recognition, Visual | 2 | 2005 | 35 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 227 | 0.030 |
Why?
| | Computer Simulation | 1 | 2016 | 249 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2015 | 128 | 0.030 |
Why?
| | Self Efficacy | 1 | 2014 | 65 | 0.030 |
Why?
| | Medicare Part D | 1 | 2013 | 7 | 0.030 |
Why?
| | ROC Curve | 1 | 2014 | 153 | 0.030 |
Why?
| | Dietary Supplements | 2 | 2005 | 62 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2013 | 257 | 0.030 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2012 | 16 | 0.030 |
Why?
| | Protein Array Analysis | 1 | 2012 | 11 | 0.030 |
Why?
| | Phosphoserine | 1 | 2012 | 5 | 0.030 |
Why?
| | Cerebellar Cortex | 1 | 2012 | 8 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2012 | 30 | 0.030 |
Why?
| | Multilevel Analysis | 1 | 2012 | 8 | 0.030 |
Why?
| | Databases, Factual | 1 | 2014 | 391 | 0.030 |
Why?
| | Aniline Compounds | 1 | 2012 | 40 | 0.030 |
Why?
| | Thiazoles | 1 | 2012 | 38 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 45 | 0.030 |
Why?
| | Models, Genetic | 1 | 2012 | 37 | 0.030 |
Why?
| | Drug Resistance | 1 | 2012 | 68 | 0.030 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 4 | 0.030 |
Why?
| | Causality | 1 | 2011 | 58 | 0.030 |
Why?
| | Glucose | 1 | 2012 | 76 | 0.030 |
Why?
| | Temporal Lobe | 1 | 2012 | 112 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 46 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 95 | 0.030 |
Why?
| | Phosphorylation | 1 | 2012 | 199 | 0.030 |
Why?
| | Niacinamide | 1 | 2011 | 4 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2012 | 295 | 0.030 |
Why?
| | Trail Making Test | 1 | 2010 | 3 | 0.030 |
Why?
| | Wine | 1 | 2010 | 7 | 0.030 |
Why?
| | Nutrition Policy | 1 | 2010 | 12 | 0.030 |
Why?
| | Insulin | 1 | 2012 | 116 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2012 | 176 | 0.030 |
Why?
| | Dendritic Spines | 1 | 2010 | 12 | 0.030 |
Why?
| | Dendrites | 1 | 2010 | 16 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2011 | 364 | 0.020 |
Why?
| | Piperazines | 1 | 2011 | 99 | 0.020 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2010 | 41 | 0.020 |
Why?
| | Retirement | 1 | 2009 | 11 | 0.020 |
Why?
| | Internet | 1 | 2011 | 103 | 0.020 |
Why?
| | Mechanoreceptors | 1 | 2009 | 7 | 0.020 |
Why?
| | Proprioception | 1 | 2009 | 21 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2011 | 548 | 0.020 |
Why?
| | Patient Compliance | 1 | 2010 | 200 | 0.020 |
Why?
| | Synaptosomes | 1 | 2008 | 8 | 0.020 |
Why?
| | Tissue Extracts | 1 | 2008 | 17 | 0.020 |
Why?
| | Ergometry | 1 | 2008 | 3 | 0.020 |
Why?
| | Protein Transport | 1 | 2008 | 42 | 0.020 |
Why?
| | Signal Transduction | 1 | 2012 | 588 | 0.020 |
Why?
| | Cytosol | 1 | 2008 | 61 | 0.020 |
Why?
| | Joints | 1 | 2009 | 101 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2008 | 90 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2008 | 140 | 0.020 |
Why?
| | Algorithms | 1 | 2011 | 412 | 0.020 |
Why?
| | Observation | 1 | 2007 | 16 | 0.020 |
Why?
| | Aspirin | 1 | 2008 | 90 | 0.020 |
Why?
| | Visual Acuity | 1 | 2007 | 48 | 0.020 |
Why?
| | Psychotropic Drugs | 1 | 2007 | 30 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2010 | 703 | 0.020 |
Why?
| | Forecasting | 1 | 2006 | 134 | 0.020 |
Why?
| | Verbal Behavior | 1 | 2005 | 22 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2005 | 53 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2005 | 40 | 0.020 |
Why?
| | Mice | 1 | 2011 | 1894 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2009 | 385 | 0.020 |
Why?
| | Community Mental Health Centers | 1 | 2005 | 5 | 0.020 |
Why?
| | Cultural Diversity | 1 | 2005 | 31 | 0.020 |
Why?
| | Acid Etching, Dental | 1 | 2005 | 2 | 0.020 |
Why?
| | Hardness | 1 | 2005 | 4 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 43 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2005 | 10 | 0.020 |
Why?
| | alpha-Tocopherol | 1 | 2005 | 9 | 0.020 |
Why?
| | Cementation | 1 | 2005 | 33 | 0.020 |
Why?
| | gamma-Tocopherol | 1 | 2005 | 9 | 0.020 |
Why?
| | Gene Frequency | 1 | 2005 | 80 | 0.020 |
Why?
| | Elasticity | 1 | 2005 | 53 | 0.020 |
Why?
| | Logic | 1 | 2004 | 3 | 0.020 |
Why?
| | Surface Properties | 1 | 2005 | 139 | 0.020 |
Why?
| | Comprehension | 1 | 2004 | 31 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2005 | 248 | 0.020 |
Why?
| | Health Status Indicators | 1 | 2005 | 82 | 0.020 |
Why?
| | Cues | 1 | 2004 | 74 | 0.020 |
Why?
| | Materials Testing | 1 | 2005 | 140 | 0.020 |
Why?
| | Sick Role | 1 | 2004 | 15 | 0.020 |
Why?
| | Speech Perception | 1 | 2004 | 56 | 0.020 |
Why?
| | Probability | 1 | 2004 | 104 | 0.020 |
Why?
| | Sampling Studies | 1 | 2003 | 32 | 0.020 |
Why?
| | Eicosapentaenoic Acid | 1 | 2003 | 7 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2003 | 10 | 0.020 |
Why?
| | Docosahexaenoic Acids | 1 | 2003 | 10 | 0.020 |
Why?
| | Heart Failure | 1 | 2007 | 232 | 0.020 |
Why?
| | beta Carotene | 1 | 2002 | 14 | 0.010 |
Why?
| | Walking | 1 | 2005 | 249 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 2002 | 39 | 0.010 |
Why?
| | Cluster Analysis | 1 | 2002 | 55 | 0.010 |
Why?
| | Hypotension | 1 | 2002 | 28 | 0.010 |
Why?
| | Dominance, Cerebral | 1 | 2002 | 24 | 0.010 |
Why?
| | Semantics | 1 | 2002 | 24 | 0.010 |
Why?
| | Arousal | 1 | 2002 | 56 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2002 | 140 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2002 | 390 | 0.010 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|